Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Pre-Close Trading Update

17 May 2017 07:00

RNS Number : 3487F
Ideagen PLC
17 May 2017
 

This announcement contains inside information.

 

 

17 May 2017

 

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

 

Pre-Close Trading Update

 

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, is pleased to provide an update on trading for the year ended 30 April 2017 ahead of the announcement of its full year results on or around 18 July 2017.

 

The Board is pleased to report that results to 30 April 2017 are expected to be in line with market expectations and that trading was once again robust across all key verticals, with particular success within the Life Sciences, Aviation and Financial sectors. The Group delivered organic revenue growth* of approximately 10 per cent together with further contributions from all four acquisitions made during the year. This represents the Group's eighth consecutive year of revenue and adjusted EBITDA** growth.

 

The Group expects to report revenue of approximately £27.1million, (FY2016: £21.9 million) and adjusted EBITDA** of approximately £7.8 million (FY2016: £6.3 million), both having increased by approximately 24%, and a significant increase in adjusted EPS***, which continues to be an important financial metric for the Group.

 

The Board is confident that the transition from a traditional 'perpetual licence' business model to a 'subscription licence' model is well underway, as evidenced by a significant increase in the run-rate of recurring revenues. This has been driven primarily by the success of Coruson, our SaaS based enterprise Risk and Safety Management solution which is allowing the Group to win larger contracts and grow high visibility, subscription-based revenue. 

 

Cash generation was extremely strong at the end of the financial year and accordingly net cash at 30 April 2017 was significantly ahead of market forecasts at £4.2 million (31 October 2016: £4.8 million), even after paying £4.6 million of consideration for the acquisitions of IPI Solutions and Gael (deferred) and £0.3 million in dividends. The Board expects to report that cash generated by operations will be in excess of 100% of adjusted EBITDA**.

 

 

David Hornsby, Chief Executive, commented: "We are pleased to report that the Group has continued to perform well in delivering another year of high quality earnings growth underpinned by strong cash generation. We have also made four important acquisitions which have provided scale, product capability and recurring revenues. We continue to grow organically and to increase the percentage of our revenues derived from recurring business. The Group has significant contracted work in progress and a strong pipeline of new business opportunities which provides the Board with confidence for the current year and beyond."

 

* FY2016 comparator prepared on a proforma basis as if these acquisitions had occurred during that year

**Earnings before interest, tax, depreciation, amortisation, share based payments, acquisition costs and other exceptional items.

***Adjusted diluted earnings per share

 

Enquiries:

Ideagen plc

01629 699100

David Hornsby, Chief Executive

 

Graeme Spenceley, Finance Director

 

 

 

finnCap Limited

020 7220 0500

Stuart Andrews/Henrik Persson/James Thompson (Nomad)

 

Stephen Norcross (Corporate Broking)

 

 

 

 

 

 About Ideagen plc

Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in GRC (Governance, Risk and Compliance) and Content and Clinical solutions with a primary focus on organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete information lifecycle solutions that enable organisations to reduce risk, meet their regulatory and compliance standards, helping them to reduce costs and improve efficiency.

The Group has a customer base of over 3,000 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.

For further information please visit www.ideagen.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDQLFFDEFXBBK
Date   Source Headline
22nd Oct 201911:26 amRNSHolding(s) in Company
17th Oct 20193:32 pmRNSDirector/PDMR Shareholding
11th Oct 20197:00 amRNSAcquisition of Optima Diagnostics Limited
7th Oct 20193:29 pmRNSNotice of AGM
4th Oct 201910:45 amRNSExercise of Options, Issue of Shares and TVR
1st Oct 20197:00 amRNSExercise of Options, Issue of Shares and TVR
25th Sep 20197:00 amRNSRedland Acquisition Update - New Contract Wins
17th Sep 20197:00 amRNSDirector Dealing and Total Voting Rights
13th Sep 201912:08 pmRNSIssue of shares under the Share Incentive Plan
3rd Sep 20198:48 amRNSHolding(s) in Company
27th Aug 20192:21 pmRNSExercise of Options and Issue of Shares
14th Aug 20194:04 pmRNSIssue of New Shares under the Share Incentive Plan
30th Jul 201912:26 pmRNSHolding(s) in Company
22nd Jul 20194:20 pmRNSIssue of New Shares under the Share Incentive Plan
17th Jul 20197:00 amRNSPreliminary Results
19th Jun 201910:24 amRNSHolding(s) in Company
10th Jun 20197:00 amRNSAcquisition of Redland Solutions Ltd
30th May 20197:00 amRNSContract Award with New Tier 1 Airline Customer
15th May 20197:00 amRNSCapital Markets Day
14th May 20197:00 amRNSTrading Statement
12th Apr 20192:43 pmRNSDirector Dealings
11th Apr 20195:06 pmRNSIssue of Shares, Director Dealings and TVR
29th Mar 20197:00 amRNSExtension to 2018 Long Term Incentive Plan awards
25th Feb 20198:00 amRNSExercise of Options and Issue of Shares
30th Jan 201910:03 amRNSExercise of Options and issue of shares
28th Jan 20194:33 pmRNSIssue of new shares under the Share Incentive Plan
22nd Jan 20197:00 amRNSUnaudited Interim Results
21st Jan 20198:46 amRNSHolding(s) in Company
15th Jan 20197:00 amRNSAppointment of Joint Broker
14th Jan 20197:00 amRNSAcquisition of Scannell Solutions Ltd
11th Dec 20183:37 pmRNSIssue of Shares, Director Dealings and TVR
5th Dec 20182:54 pmRNSHolding(s) in Company
22nd Nov 201812:12 pmRNSHolding(s) in Company
21st Nov 20187:57 amRNSHolding(s) in Company
20th Nov 201812:04 pmRNSHolding(s) in Company
19th Nov 20185:56 pmRNSHolding(s) in Company
13th Nov 20187:00 amRNSTrading Update
30th Oct 20182:28 pmRNSResult of AGM
24th Oct 20182:35 pmRNSExercise of Options and Total Voting Rights
23rd Oct 201811:19 amRNSHolding(s) in Company
23rd Oct 20187:00 amRNS2018 Long Term Incentive Plan awards
12th Oct 20183:26 pmRNSHolding(s) in Company
10th Oct 20184:18 pmRNSHolding(s) in Company
8th Oct 201812:46 pmRNSIssue of Shares and Total Voting Rights
8th Oct 20187:00 amRNSPosting of Annual Report and Notice of AGM
5th Oct 20187:00 amRNSDirectors' Dealings
3rd Oct 20184:36 pmRNSExercise of Options & Total Voting Rights
2nd Oct 20184:38 pmRNSHolding(s) in Company
2nd Oct 20184:37 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSAcquisition of Morgan Kai Group Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.